Don't jump on the bandwaggon.
This tiny biotech caught fire in 2024. Can it sustain the momentum?
Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according...
OCGN earnings call for the period ending March 31, 2024.
Could these biotech companies still win in the vaccine market and beyond?
OCGN earnings call for the period ending September 30, 2023.
OCGN earnings call for the period ending June 30, 2023.
These companies haven't given up on the coronavirus vaccine market.
OCGN earnings call for the period ending March 31, 2023.
The company is clearly progressing on several fronts with its pipeline programs.